Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.010 AlteredExpression disease BEFREE In the present pilot study, we investigated plasma adiponectin levels in a cohort of 56 individuals with a genetic diagnosis of Fabry disease. 31715450 2020
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.010 Biomarker disease BEFREE Gene expression studies revealed higher mRNA levels of CCL2, INF-γ, and Notch1 in FD fibroblasts compared to controls at baseline and after TNF incubation (p < .05 each), while TGF-β1 was higher in FD fibroblasts only after incubation with TNF (p < .05). 31778662 2020
Entrez Id: 5420
Gene Symbol: PODXL
PODXL
0.010 AlteredExpression disease BEFREE Correlations were established between podocalyxin and podocin levels and clinical parameters associated with Fabry disease and preeclampsia. 30898510 2019
Entrez Id: 5476
Gene Symbol: CTSA
CTSA
0.010 GeneticVariation disease BEFREE Several types of monogenic, hereditary cerebral SVD have been identified: cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL), hereditary diffuse leukoencephalopathy with spheroids (HDLS), <i>COL4A1/2</i>-related disorders, and Fabry disease. 31484286 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.010 Biomarker disease BEFREE We investigated the relationship between T1 mapping and 18F-FDG uptake by hybrid PET-MR cardiac imaging in AFD female patients. 30879055 2019
Entrez Id: 5730
Gene Symbol: PTGDS
PTGDS
0.010 Biomarker disease BEFREE Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. 30996283 2019
Entrez Id: 3565
Gene Symbol: IL4
IL4
0.010 Biomarker disease BEFREE TNF and IL-10 were higher, and IL-4 was lower in the subgroup of FD men with pain compared to controls (p < .05 to p < .01). 31221509 2019
Entrez Id: 3306
Gene Symbol: HSPA2
HSPA2
0.010 Biomarker disease BEFREE Quantitative proteomics enabled the identification of >5,500 proteins in the cardiomyocyte proteome and secretome, and revealed accumulation of the lysosomal protein LIMP-2 and secretion of cathepsin F and HSPA2/HSP70-2 in FD. 31378672 2019
Entrez Id: 3958
Gene Symbol: LGALS3
LGALS3
0.010 Biomarker disease BEFREE Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. 30996283 2019
Entrez Id: 7099
Gene Symbol: TLR4
TLR4
0.010 AlteredExpression disease BEFREE We found increased TNF, interleukin (IL-)1β, and toll-like receptor 4 (TLR4) gene expression in FD men (p < .05 to p < .01). 31221509 2019
Entrez Id: 8722
Gene Symbol: CTSF
CTSF
0.010 Biomarker disease BEFREE Quantitative proteomics enabled the identification of >5,500 proteins in the cardiomyocyte proteome and secretome, and revealed accumulation of the lysosomal protein LIMP-2 and secretion of cathepsin F and HSPA2/HSP70-2 in FD. 31378672 2019
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.010 Biomarker disease BEFREE These results suggest that GLA deficiency promotes VWF secretion through eNOS dysregulation, which may contribute to the vasculopathy of Fabry disease. 30470436 2019
Entrez Id: 3934
Gene Symbol: LCN2
LCN2
0.010 Biomarker disease BEFREE Evaluation of Beta 2-Microglobulin, Cystatin C, and Lipocalin-2 as Renal Biomarkers for Patients with Fabry Disease. 31216546 2019
Entrez Id: 6609
Gene Symbol: SMPD1
SMPD1
0.010 Biomarker disease BEFREE We present the unusual case of a 12-year-old girl with acid sphingomyelinase deficiency who developed characteristic lesions of angiokeratoma corporis diffusum. 31576605 2019
Entrez Id: 3303
Gene Symbol: HSPA1A
HSPA1A
0.010 Biomarker disease BEFREE Quantitative proteomics enabled the identification of >5,500 proteins in the cardiomyocyte proteome and secretome, and revealed accumulation of the lysosomal protein LIMP-2 and secretion of cathepsin F and HSPA2/HSP70-2 in FD. 31378672 2019
Entrez Id: 3304
Gene Symbol: HSPA1B
HSPA1B
0.010 Biomarker disease BEFREE Quantitative proteomics enabled the identification of >5,500 proteins in the cardiomyocyte proteome and secretome, and revealed accumulation of the lysosomal protein LIMP-2 and secretion of cathepsin F and HSPA2/HSP70-2 in FD. 31378672 2019
Entrez Id: 950
Gene Symbol: SCARB2
SCARB2
0.010 Biomarker disease BEFREE Quantitative proteomics enabled the identification of >5,500 proteins in the cardiomyocyte proteome and secretome, and revealed accumulation of the lysosomal protein LIMP-2 and secretion of cathepsin F and HSPA2/HSP70-2 in FD. 31378672 2019
Entrez Id: 4907
Gene Symbol: NT5E
NT5E
0.010 Biomarker disease BEFREE The aim of the present study was to investigate the cochleovestibular manifestations of FD, in order to show the importance of screening and systematic ENT evaluation. 31072727 2019
Entrez Id: 7827
Gene Symbol: NPHS2
NPHS2
0.010 AlteredExpression disease BEFREE Correlations were established between podocalyxin and podocin levels and clinical parameters associated with Fabry disease and preeclampsia. 30898510 2019
Entrez Id: 3425
Gene Symbol: IDUA
IDUA
0.010 Biomarker disease BEFREE The incidences of Pompe and Gaucher diseases were similar (1/22,205), with Fabry disease the most frequent (1/8882) and MPS-I the rarest (1/44411). 29143201 2018
Entrez Id: 406913
Gene Symbol: MIR126
MIR126
0.010 Biomarker disease BEFREE A literature and database search revealed that miR-199a-5p, miR-126-3p, miR-423-5p and miR-451a are known to be linked to pathological states that occur during the FD development. 29937989 2018
Entrez Id: 162083
Gene Symbol: C16orf82
C16orf82
0.010 Biomarker disease BEFREE Hs-TNT and NT-proBNP levels were significantly higher in the CA group [median: hs-TNT 98 pg/mL, NT-proBNP 4,110 pg/mL] than in the FA group [hs-TNT 14 pg/mL, NT-proBNP 40 pg/mL] and FD group [hs-TNT 18 pg/mL, NT-proBNP 131 pg/mL, both P<0.001]. 30233871 2018
Entrez Id: 574411
Gene Symbol: MIR451A
MIR451A
0.010 Biomarker disease BEFREE A literature and database search revealed that miR-199a-5p, miR-126-3p, miR-423-5p and miR-451a are known to be linked to pathological states that occur during the FD development. 29937989 2018
Entrez Id: 6232
Gene Symbol: RPS27
RPS27
0.010 Biomarker disease BEFREE The incidences of Pompe and Gaucher diseases were similar (1/22,205), with Fabry disease the most frequent (1/8882) and MPS-I the rarest (1/44411). 29143201 2018
Entrez Id: 219972
Gene Symbol: MPEG1
MPEG1
0.010 Biomarker disease BEFREE The incidences of Pompe and Gaucher diseases were similar (1/22,205), with Fabry disease the most frequent (1/8882) and MPS-I the rarest (1/44411). 29143201 2018